Schedule of Valuation Methodology and Significant Unobservable Inputs (Details) |
3 Months Ended | 12 Months Ended |
|---|---|---|
Mar. 31, 2026 |
Dec. 31, 2025 |
|
| Input One [Member] | ||
| Business Combination [Line Items] | ||
| Value Used | Probability of Default -Tranches A & B (Ratings 2–5, pooled) | |
| Probability of Default -Tranches A & B (Ratings 2–5, pooled) [Member] | ||
| Business Combination [Line Items] | ||
| Value Used | 7.25%, derived from loan level analysis of the portfolio. | 7.25%, derived from loan level analysis of the portfolio. |
| Sensitivity | An increase raises fair value | An increase raises fair value |
| Input | Probability of Default -Tranches A & B (Ratings 2–5, pooled) | |
| Probability of Default - Tranche C (Rating 9, individually evaluated) [Member] | ||
| Business Combination [Line Items] | ||
| Value Used | 35%, based on Rating 9 definition, past-maturity status, and personal guarantees | 35%, based on Rating 9 definition, past-maturity status, and personal guarantees |
| Sensitivity | An increase raises fair value | An increase raises fair value |
| Input | Probability of Default - Tranche C (Rating 9, individually evaluated) | |
| Loss Given Default - Tranches A & B [Member] | ||
| Business Combination [Line Items] | ||
| Value Used | 25.00% for Tranche A and 35% for Tranche B, inclusive of 13% cannabis-specific qualitative premium reflecting court access limitations, collateral possession restrictions, and refinancing risk | 25.00% for Tranche A and 35% for Tranche B, inclusive of 13% cannabis-specific qualitative premium reflecting court access limitations, collateral possession restrictions, and refinancing risk |
| Sensitivity | An increase raises fair value | An increase raises fair value |
| Input | Loss Given Default - Tranches A & B | |
| Loss Given Default - Tranche C (uncollateralized gap) [Member] | ||
| Business Combination [Line Items] | ||
| Value Used | 50%, representing the midpoint of the Rating 9 anticipated loss range applied to the uncollateralized exposure | 50%, representing the midpoint of the Rating 9 anticipated loss range applied to the uncollateralized exposure |
| Sensitivity | An increase raises fair value | An increase raises fair value |
| Input | Loss Given Default - Tranche C (uncollateralized gap) | |
| Stand-Ready Risk Premium [Member] | ||
| Business Combination [Line Items] | ||
| Value Used | 120% loading applied to total expected loss, reflecting compensation for uncapped exposure, cannabis concentration risk, portfolio illiquidity, and six-year guarantee term commitment | 120% loading applied to total expected loss, reflecting compensation for uncapped exposure, cannabis concentration risk, portfolio illiquidity, and six-year guarantee term commitment |
| Sensitivity | An increase raises fair value | An increase raises fair value |
| Input | Stand-Ready Risk Premium | |
| Measurement Input, Discount Rate [Member] | ||
| Business Combination [Line Items] | ||
| Value Used | 4.0% risk-free rate (6-year Treasury) | 4.0% risk-free rate (6-year Treasury) |
| Sensitivity | An increase reduces fair value | An increase reduces fair value |
| Input | Discount Rate | |
| Weighted Average Payout Timing [Member] | ||
| Business Combination [Line Items] | ||
| Value Used | Tranche A: 4 years; Tranche B: 3 years; Tranche C: 2 years; Stand-ready premium: 3 years — based on the portfolio’s contractual maturity profile | Tranche A: 4 years; Tranche B: 3 years; Tranche C: 2 years; Stand-ready premium: 3 years — based on the portfolio’s contractual maturity profile |
| Sensitivity | A longer weighted average payout timing reduces fair value | A longer weighted average payout timing reduces fair value |
| Input | Weighted Average Payout Timing |